Interview with Carlos Mayotti, Commercial Director, Phoenix
How has Phoenix developed from being the family company that was founded seventy years ago into the successful corporate business it is today? I joined Phoenix in 1989, at that…
Address: Ave Gen. J. Lemos 2809 (B1614BDH). Villa de Mayo. Buenos Aires. Argentina.
Tel: (54-11) 4489-8300
Web: http://www.phoenix.com.ar/
A Commitment to Health is what characterizes the more than half-a-century of activity carried out by Laboratorios Phoenix, a pioneer in offering to the domestic market the product of state-of-the-art international research, including the first antibiotics and antipoliomyelitic vaccines.
Throughout its trajectory, Laboratorios Phoenix has contributed to the growth of the Argentine pharmaceutical industry, assuring up-to-date scientific dissemination and production of drugs according to the most demanding standards of quality control.
As a licensee, Laboratorios Phoenix has demonstrated in its production an entrepreneurial soundness and scientific rigor in accordance with the standards of important foreign laboratories. And as a result of creative innovation, it has also made its own achievements in the field of leading edge research, developing state-of-the art technology in the area of oral drug delivery and controlled drug release.
Opthamology, Dermatology, Neurological, Respiratory
How has Phoenix developed from being the family company that was founded seventy years ago into the successful corporate business it is today? I joined Phoenix in 1989, at that…
Writing in the July 2023 edition of DIA’s Global Forum magazine, Mariana Abdala of Crystal Research outlines the vast room for improvement in Latin America’s clinical trial output, the region’s…
Japanese-headquartered Takeda has been undergoing a transformation in recent years, becoming the global leader in rare diseases with the acquisition of Shire in 2018 and divesting ‘non-core’ assets in OTC…
Argentinian generics manufacturer Grupo Roemmers – which celebrated its 100-year anniversary in 2021 – has expanded steadily across the Latin America and Caribbean region since the mid-1970s with a successful…
While Bayer’s recent history has been dominated by the controversial Monsanto acquisition, the German firm will be hoping for a more straightforward next few years with a new leadership team…
Argentinian generics manufacturer Grupo Roemmers – which celebrated its 100-year anniversary in 2021 – has expanded steadily across the Latin America and Caribbean region since the mid-1970s with a successful…
Axios International has been designing and implementing access to healthcare solutions in collaboration with the pharmaceutical industry and other healthcare players across Latin America (LatAm), Europe, the Middle East, Africa,…
Maria Gabriela Pittis, Head of SAM (South Cone, Andean Region, Mexico & Central America and Caribbean) at Takeda, outlines the company’s significant presence in the cluster, its double digit growth…
Florencia Davel, head of LatAm operations for Bristol Myers Squibb (BMS) looks back on a successful four years in position, shaping the regional organisation into a true biopharma player in…
The Head of Viatris Latin America, Patrick Doyle, spoke to PharmaBoardroom about setting up the two-year old company’s Latam affiliate during the pandemic, the decision to focus on specific therapeutic…
Boehringer Ingelheim’s managing director for South America, Dirk van Niekerk, provides an overview of the healthcare climate in South America, the challenges tied to political and economic instability, future opportunities…
Dr Guillermo Chantada, incoming president-elect of the International Society of Paediatric Oncology (SIOP) highlights the progress of paediatric oncology in Latin America and gives a call to arms to the…
PharmaBoardroom spoke to Fabrice Chouraqui, President of Novartis Latin America and Canada at the Financial Times LatAm Healthcare & Life Sciences Summit in September 2015. He emphasizes the criticality of…
See our Cookie Privacy Policy Here